Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson’s disease

• Published in: NPJ Parkinson's Disease Vol. 10; no. 1; pp. 29 - 9
• Main Authors: Torres, Viviana, Del Giudice, Kirsys, Roldán, Pedro, Rumià, Jordi, Muñoz, Esteban, Cámara, Ana, Compta, Yaroslau, Sánchez-Gómez, Almudena, Valldeoriola, Francesc
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27.01.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/1689/364; 692/617/375/346/1718; Biomedical and Life Sciences; Biomedicine; Clinical outcomes; Deep brain stimulation; Neurology; Neurosciences; Parkinson's disease
• ISSN: 2373-8057; 2373-8057
• DOI: 10.1038/s41531-024-00639-9

Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson’s disease (PD). However, some patients may not respond optimally to clinical programming adjustments. Advances in DBS technology have led to more complex and time-consuming programming. Image-guided programming (IGP) could optimize and improve programming leading to better clinical outcomes in patients for whom DBS programming is not ideal due to sub-optimal response. We conducted a prospective single-center study including 31 PD patients with subthalamic nucleus (STN) DBS and suboptimal responses refractory to clinical programming. Programming settings were adjusted according to the volumetric reconstruction of the stimulation field using commercial postoperative imaging software. Clinical outcomes were assessed at baseline and at 3-month follow-up after IGP, using motor and quality of life (QoL) scales. Additionally, between these two assessment points, follow-up visits for fine-tuning amplitude intensity and medication were conducted at weeks 2, 4, 6, and 9. After IGP, twenty-six patients (83.9%) experienced motor and QoL improvements, with 25.8% feeling much better and 38.7% feeling moderately better according to the patient global impression scale. Five patients (16.1%) had no clinical or QoL changes after IGP. The MDS-UPDRS III motor scale showed a 21.9% improvement and the DBS-IS global score improved by 41.5%. IGP optimizes STN-DBS therapy for PD patients who are experiencing suboptimal clinical outcomes. These findings support using IGP as a standard tool in clinical practice, which could save programming time and improve patients’ QoL.